Jul 28, 09:07
78% of moneycontrol users recommend buying Piramal Enter.
What's your call on Piramal Enter today?
Read 25 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2766.70||0.76||2939.80||2140.35||47,126.60|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
Visaka Industries Recommended on Jun 16th 2014
Recommended price 101.00 | Peak from reco 133.55 31.71%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Piramal Enter is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 10,950.85 crore.The company has reported a consolidated sales of Rs 1,110.38 crore and a Net Loss of Rs -310.45 crore for the quarter ended Mar 2014.
The company management includes Ajay G Piramal - Chairman, Swati A Piramal - Vice Chairman, Nandini Piramal - Executive Director, Vijay Shah - COO & Executive Director, Gautam Banerjee - Non Executive Director, Amit Chandra - Director, Keki Dadiseth - Director, R A Mashelkar - Director, Goverdhan Mehta - Director, Siddharth Mehta - Ind.& Non Exe.Director, S Ramadorai - Director, Deepak Satwalekar - Director, N Vaghul - Director.
It is listed on the BSE with a BSE Code of 500302 and the NSE with an NSE Code of PEL.
Its Registered office is at Piramal Tower, Ganpatrao Kadam Marg,,Lower Parel Mumbai,Maharashtra - 400013.
Their Registrars are Link Intime India Pvt. Ltd.